Prot #APG1252SU101: A Multi-Center, Phase Ib/II Study of Combination Treatment of APG-1252 with Paclitaxel in Patients with Relapsed/Refractory Small Cell Lung Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date8/20/20 → 8/20/23

Funding

  • Ascentage Pharma Group, Inc (Prot #APG1252SU101)